Pear Therapeutics

Product Pipeline

Product/
Candidate
Therapeutic
Area
Stage

Discovery POC FDA
Presub
Pivotal
Studies
FDA
Submission
FDA
Authorization

 

Academic
Partner

 

Commercial
Partner

Substance Use
Disorder

Opioid Use
Disorder

Somryst™ * Insomnia/
Depression

PEAR-004 * Schizophrenia
(Pos Sx)

DISCOVERY * Cognition

DISCOVERY * Epilepsy

reCALL™ * PTSD

PEAR-007 * Pain

DISCOVERY * Movement Disorders

PEAR-006 * Multiple Sclerosis

DISCOVERY * Migraine

DISCOVERY * Autism Spectrum Disorder

DISCOVERY * Oncology, Inflammation, CV, GI, Respiratory

* FDA has not determined the safety or effectiveness of this product candidate.